IL10 and metabolic syndrome: It has been reported that MSC-EVs isolated from adipose tissues can improve the structure and function of the kidney and reduce kidney damage and dysfunction by upregulating interleukin 10 (IL-10) expression in a new porcine model of metabolic syndrome (METS) and renal artery stenosis (RAS) [77].